A selective LIS1 requirement for mitotic spindle assembly discriminates distinct T-cell division mechanisms within the T-cell lineage.
Jérémy ArgentyNelly RouquiéCyrielle BoriesSuzanne MéliqueValérie Duplan-EcheAbdelhadi SaoudiNicolas FazilleauRenaud LesournePublished in: eLife (2022)
The ability to proliferate is a common feature of most T-cell populations. However, proliferation follows different cell-cycle dynamics and is coupled to different functional outcomes according to T-cell subsets. Whether the mitotic machineries supporting these qualitatively distinct proliferative responses are identical remains unknown. Here, we show that disruption of the microtubule-associated protein LIS1 in mouse models leads to proliferative defects associated with a blockade of T-cell development after β-selection and of peripheral CD4+ T-cell expansion after antigen priming. In contrast, cell divisions in CD8+ T cells occurred independently of LIS1 following T-cell antigen receptor stimulation, although LIS1 was required for proliferation elicited by pharmacological activation. In thymocytes and CD4+ T cells, LIS1 deficiency did not affect signaling events leading to activation but led to an interruption of proliferation after the initial round of division and to p53-induced cell death. Proliferative defects resulted from a mitotic failure, characterized by the presence of extra-centrosomes and the formation of multipolar spindles, causing abnormal chromosomes congression during metaphase and separation during telophase. LIS1 was required to stabilize dynein/dynactin complexes, which promote chromosome attachment to mitotic spindles and ensure centrosome integrity. Together, these results suggest that proliferative responses are supported by distinct mitotic machineries across T-cell subsets.
Keyphrases
- cell cycle
- cell proliferation
- cell death
- signaling pathway
- single cell
- mouse model
- machine learning
- peripheral blood
- magnetic resonance
- magnetic resonance imaging
- deep learning
- computed tomography
- cell therapy
- bone marrow
- mass spectrometry
- dna methylation
- endothelial cells
- contrast enhanced
- oxidative stress
- genetic diversity